Hostname: page-component-848d4c4894-tn8tq Total loading time: 0 Render date: 2024-06-17T15:06:38.368Z Has data issue: false hasContentIssue false
  • English
  • Français

Bipolar disorder’s treatment and impulsivity

Published online by Cambridge University Press:  13 August 2021

S. Ajmi ,
S. Najjar  and
J. Masmoudi
S. Ajmi*
Affiliation:
Psychiatrie A, hospital University Hedi Chaker, sfax, Tunisia
S. Najjar
Affiliation:
Psychiatry A, hedi chaker hospital, Sfax, Tunisia
J. Masmoudi
Affiliation:
Psychiatrie “a” Department, Hedi Chaker Hospital University -Sfax - Tunisia, sfax, Tunisia
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Impulsivity is not a classical psychiatric diagnosis like schizophrenia, depression, bipolar or borderline personality disorder. It is a symptom that could occur in almost all psychiatric disorders and in some neurological or systemic diseases.

Objectives

In this study we examine the influence of bipolar disorder’s (BD) treatment on the impulsivity.

Methods

We performed a cross sectional study on 30 patients diagnosed with BD and consulting at the Psychiatric department of HediChaker Hospital. Patients were euthymic during the time of the study confirmed by administration Young Mania Rating Scale (YMRS) and Montgomery Depression Rating Scale (MDRS). The socio-demographic data and treatment models were obtained. Impulsivity was evaluated using the Barratt Impulsiveness Scale (BIS-11).

Results

The study sample consisted of 30 patients (10 men and 20 women). The mean age of the sample was 45.83 years (SD= 11. 63). Seventeen patients (56.7%) were married. Half of the participants were using an association of mood stabilizer (MS) and an antipsychotic (AP), 36.7% and 13.3% were receiving respectively only mood stabilizer or an antipsychotic. The mean BIS11 score was 75. 60 (SD=5.51) and 76.7% had a high level of impulsivity. No correlation was found between the level of impulsivity (BIS-11 scores) and using MS, AP or MS+AP (p=0.199; p=0.933; p=0.195).

Conclusions

Further studies should be realized to identify pharmacological treatment of impulsivity among people with BD.

Keywords

ImpulsivityMood stabilizerantipsychoticbiopolar disorder
Type
Abstract
Information
European Psychiatry , Volume 64 , Special Issue S1: Abstracts of the 29th European Congress of Psychiatry , April 2021 , pp. S200
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2021. Published by Cambridge University Press on behalf of the European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.